- Vaccinia virus powered the campaign that eradicated smallpox in 1980.
- Its 192-kilobase genome makes it one of the largest DNA viruses known.
- Researchers now engineer vaccinia strains as oncolytic cancer therapies.
Vaccinia virus is a large, double-stranded DNA virus in the Orthopoxvirus genus that served as the live component of the smallpox vaccine and is now widely used as a vector in gene therapy and cancer research.
Why it matters
Key figure
1796
Year Edward Jenner performed the first vaccination
Edward Jenner's 1796 experiment established vaccination as a medical practice, and vaccinia virus was the agent that made it work. Jenner inoculated eight-year-old James Phipps with material from a cowpox lesion on milkmaid Sarah Nelmes's hand. Two months later, he exposed Phipps to smallpox. The boy remained healthy.
That experiment launched a campaign that took nearly two centuries to complete. The World Health Organization declared smallpox eradicated in 1980, the first human disease eliminated through deliberate intervention. Vaccinia virus, passed arm-to-arm and later grown in animal tissue, was the tool that made eradication possible.
The virus has since found a second career. Its 192-kilobase genome, one of the largest among DNA viruses, can accommodate substantial foreign DNA without losing replication efficiency. Researchers now engineer modified vaccinia strains to deliver therapeutic genes directly into tumors, turning a vaccine platform into an anti-cancer tool.
How it works
Vaccinia virus replicates entirely in the cytoplasm of infected cells, an unusual trait for a DNA virus. Most DNA viruses depend on the host cell's nucleus for replication, but poxviruses carry their own transcription and replication machinery encoded within that large genome.
Key figure
192 kb
Genome size, among the largest of DNA viruses
The virus enters cells through membrane fusion and immediately begins transcribing early genes using enzymes packaged inside the virion itself. These early proteins shut down host defenses and set up DNA replication. Later genes produce structural proteins that assemble into new viral particles, which exit the cell either by budding through the membrane or by lysing the cell entirely.
This self-sufficiency is what makes vaccinia valuable as a vector. Researchers delete genes responsible for virulence (most commonly the thymidine kinase gene, J2R) and insert therapeutic sequences in their place. The modified virus still replicates in target cells but cannot spread efficiently in healthy tissue.
In oncolytic applications, engineered vaccinia strains selectively infect tumor cells. Tumor cells overexpress thymidine kinase and support viral replication even when the viral TK gene is removed. The virus kills cancer cells directly and can trigger an immune response against the tumor.
Key context
Allan Watt Downie demonstrated in 1939 that the virus used in smallpox vaccines was serologically distinct from cowpox. Vaccinia was subsequently classified as a separate species. Its true origin remains debated: genomic analysis published in npj Vaccines in 2022 confirmed that vaccinia is most closely related to horsepox, suggesting the vaccine strain diverged from Jenner's original cowpox material at some point during the nineteenth century.
Several oncolytic vaccinia candidates have advanced through clinical trials. GL-ONC1, a modified vaccinia strain developed by Genelux Corporation, completed phase I/II testing in patients with peritoneal carcinomatosis. A recombinant strain expressing human interleukin-21 (hV01) entered phase I trials, with early results suggesting that intratumoral IL-21 expression can reshape the tumor microenvironment.
FAQ
Is vaccinia virus the same as cowpox?
No. Allan Watt Downie showed in 1939 that vaccinia is serologically distinct from cowpox. Genomic studies suggest vaccinia likely descended from horsepox, not cowpox, and diverged from Jenner's original material during the nineteenth century.
Can vaccinia virus cause smallpox?
Vaccinia cannot cause smallpox. It belongs to the same Orthopoxvirus genus as variola (the smallpox virus), but it is a separate species that produces only mild, localized symptoms in healthy individuals. That close relationship is what allows vaccinia to generate cross-protective immunity against smallpox.
How is vaccinia virus used in cancer treatment?
Researchers engineer vaccinia strains with deleted virulence genes so the virus replicates selectively in tumor cells. These oncolytic vaccinia viruses kill cancer cells directly and trigger an immune response against the tumor. Several candidates, including GL-ONC1, have advanced through clinical trials.
Why was vaccinia virus chosen for the smallpox vaccine?
Vaccinia produces a mild infection that generates strong cross-immunity against smallpox. Its stability outside the body, ability to grow in various cell cultures, and tolerance for genetic modification made it practical for mass production and global distribution during the eradication campaign.
Sources
- Primary Research: Edward Jenner and the history of smallpox and vaccination (Riedel, S., Proceedings Baylor University Medical Center, 2005)
- Additional Context:
- Vaccinia Virus Vaccines: Past, Present and Future (Moss, B., Cold Spring Harbor Perspectives in Biology)
- Genetic ancestry and population structure of vaccinia virus (npj Vaccines, 2022)
- Oncolytic vaccinia virus and cancer immunotherapy (Frontiers in Immunology, 2024)
- History of smallpox vaccination (World Health Organization)
Fact Check: Claim-by-Claim Verification Verified
All core claims verified against primary sources. Jenner's 1796 experiment, WHO 1980 eradication declaration, Downie's 1939 serological distinction, vaccinia-horsepox genomic relationship, and oncolytic clinical trial status all confirmed accurate.
Sources used for verification
- Edward Jenner and the history of smallpox and vaccination - PMC
- Genetic ancestry and population structure of vaccinia virus - Nature
- History of smallpox vaccination - WHO
- Oncolytic vaccinia virus and cancer immunotherapy - Frontiers
- Allan Watt Downie - Royal College of Physicians
